AS

Abhishek Singhal

Active Director Director DIN 09250118
DIN 09250118 First appointment Mar 2025 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Abhishek Singhal

Data last updated:

Abhishek Singhal is a Director at Kempt Tissues Private Limited (since 2025). The company operates in Manufacturing. Kempt Tissues Private Limited reported revenue of ₹33.97 Cr (FY 2025).

DIN 09250118
Primary Designation Director
Industry Manufacturing
First Appointment 10 Mar 2025
Oldest Company Age 5 yrs
Largest company Kempt Tissues Private Limited · ₹33.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kempt Tissues Private Limited U21000GJ2021PTC120238
Director10 Mar 20252021₹33.97 Cr (FY 2025)Active

Board colleagues of Abhishek Singhal

Directorship timeline

Open interactive timeline →
Kempt Tissues Private Limited
Premium access

Shareholding and investment profile for Abhishek Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Singhal

Abhishek Singhal currently holds 1 directorship: Kempt Tissues Private Limited (Director, since 10 Mar 2025, revenue ₹33.97 Cr (FY 2025)).

Abhishek Singhal was first appointed on 10 Mar 2025 as Director at Kempt Tissues Private Limited.

The current boards of Abhishek Singhal's companies include Ajay Mor (Kempt Tissues Private Limited), Dinesh Kumar Ramgopal (Kempt Tissues Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available